Pages that link to "Q29547283"
Jump to navigation
Jump to search
The following pages link to Banting lecture 1988. Role of insulin resistance in human disease (Q29547283):
Displaying 50 items.
- Lipoprotein genotype and conserved pathway for exceptional longevity in humans (Q21146060) (← links)
- The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides (Q21261422) (← links)
- A comprehensive review on metabolic syndrome (Q21284500) (← links)
- Oral Antidiabetic Agents (Q22241436) (← links)
- Do stress reactions cause abdominal obesity and comorbidities? (Q22250952) (← links)
- Obesity: Genetic, molecular, and environmental aspects (Q22252954) (← links)
- The thrifty phenotype: An adaptation in growth or metabolism? (Q22252955) (← links)
- Hepatic steatosis: a benign disease or a silent killer (Q22305506) (← links)
- Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association (Q22306331) (← links)
- Historical Trends and Milestones in Hypertension Research: A Model of the Process of Translational Research (Q22306334) (← links)
- Metabolic syndrome and echocardiographic left ventricular mass in blacks - the atherosclerosis risk in communities (ARIC) study (Q23910922) (← links)
- Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysis (Q23920590) (← links)
- Association between depressive symptoms and metabolic syndrome in police officers: results from two cross-sectional studies (Q23922365) (← links)
- Role of ENPP1 on adipocyte maturation (Q24293330) (← links)
- GPRC5B activates obesity-associated inflammatory signaling in adipocytes (Q24304291) (← links)
- Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus (Q24310636) (← links)
- Insulin decreases the secretion of apoB-100 from hepatic HepG2 cells but does not decrease the secretion of apoB-48 from intestinal CaCo-2 cells (Q24321472) (← links)
- Molecular structure and chromosomal mapping of the human homolog of the agouti gene (Q24328758) (← links)
- Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle (Q24559986) (← links)
- An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms (Q24562942) (← links)
- Characterization of the human insulin-induced gene 2 (INSIG2) promoter: the role of Ets-binding motifs (Q24598294) (← links)
- Metabolic syndrome in the Middle East (Q24604999) (← links)
- The metabolic syndrome in Africa: Current trends (Q24605049) (← links)
- Regional differences in cellular mechanisms of adipose tissue gain with overfeeding (Q24624643) (← links)
- IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation (Q24644567) (← links)
- Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report (Q24647005) (← links)
- Impaired glucose tolerance (Q24655720) (← links)
- Traditional chinese medicine in treatment of metabolic syndrome (Q24657961) (← links)
- Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders (Q24658031) (← links)
- Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males (Q24672743) (← links)
- Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment (Q24791399) (← links)
- Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR) (Q24793496) (← links)
- Clinical significance of cardiovascular dysmetabolic syndrome (Q24794239) (← links)
- Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy (Q24796491) (← links)
- Gender differences in factors influencing insulin resistance in elderly hyperlipemic non-diabetic subjects (Q24796513) (← links)
- Low birth weight and longitudinal trends of cardiovascular risk factor variables from childhood to adolescence: the bogalusa heart study (Q24799587) (← links)
- The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome (Q24803696) (← links)
- (Q24806038) (← links)
- An evaluation of the metabolic syndrome in the HyperGEN study (Q24807170) (← links)
- Postprandial lipemia in men with metabolic syndrome, hypertensives and healthy subjects (Q24812379) (← links)
- Reversal of high dietary fructose-induced PPARalpha suppression by oral administration of lipoxygenase/cyclooxygenase inhibitors (Q24814568) (← links)
- Prevalence, predisposition and prevention of type II diabetes (Q24815863) (← links)
- Visceral adiposity syndrome (Q26738890) (← links)
- Detecting people at high risk of type 2 diabetes- How do we find them and who should be treated? (Q26739194) (← links)
- Lipid-Induced Insulin Resistance in Skeletal Muscle: The Chase for the Culprit Goes from Total Intramuscular Fat to Lipid Intermediates, and Finally to Species of Lipid Intermediates (Q26739957) (← links)
- Apoptosis in pancreatic β-islet cells in Type 2 diabetes (Q26747141) (← links)
- Insulin-Sensitizing Effects of Omega-3 Fatty Acids: Lost in Translation? (Q26748802) (← links)
- Metabolic syndrome and obesity in peritoneal dialysis (Q26748989) (← links)
- Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism? (Q26749088) (← links)
- Fetal programming and early identification of newborns at high risk of free radical-mediated diseases (Q26750488) (← links)